Works by Gomez, Baltazar

Results: 45
    1
    2
    3

    Tweaking the Social Network.

    Published in:
    Science Translational Medicine, 2012, v. 4, n. 131, p. 1, doi. 10.1126/scitranslmed.3004017
    By:
    • Gomez-Mancilla, Baltazar
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10

    AFQ056 treatment of levodopa-induced dyskinesias: Results of 2 randomized controlled trials.

    Published in:
    Movement Disorders, 2011, v. 26, n. 7, p. 1243, doi. 10.1002/mds.23616
    By:
    • Berg, Daniela;
    • Godau, Jana;
    • Trenkwalder, Claudia;
    • Eggert, Karla;
    • Csoti, IIona;
    • Storch, Alexander;
    • Huber, Heiko;
    • Morelli-Canelo, Monica;
    • Stamelou, Maria;
    • Ries, Vincent;
    • Wolz, Martin;
    • Schneider, Christine;
    • Di Paolo, Thérèse;
    • Gasparini, Fabrizio;
    • Hariry, Sam;
    • Vandemeulebroecke, Marc;
    • Abi-Saab, Walid;
    • Cooke, Katy;
    • Johns, Donald;
    • Gomez-Mancilla, Baltazar
    Publication type:
    Article
    11

    Characterization of a Clinically and Biologically Defined Subgroup of Patients with Autism Spectrum Disorder and Identification of a Tailored Combination Treatment.

    Published in:
    Biomedicines, 2024, v. 12, n. 5, p. 991, doi. 10.3390/biomedicines12050991
    By:
    • Pérez-Cano, Laura;
    • Boccuto, Luigi;
    • Sirci, Francesco;
    • Hidalgo, Jose Manuel;
    • Valentini, Samuel;
    • Bosio, Mattia;
    • Liogier D'Ardhuy, Xavier;
    • Skinner, Cindy;
    • Cascio, Lauren;
    • Srikanth, Sujata;
    • Jones, Kelly;
    • Buchanan, Caroline B.;
    • Skinner, Steven A.;
    • Gomez-Mancilla, Baltazar;
    • Hyvelin, Jean-Marc;
    • Guney, Emre;
    • Durham, Lynn
    Publication type:
    Article
    12
    13
    14

    Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial.

    Published in:
    Science Translational Medicine, 2025, v. 17, n. 792, p. 1, doi. 10.1126/scitranslmed.adi4505
    By:
    • Gomez-Mancilla, Baltazar;
    • Dürsteler, Kenneth M.;
    • Vogel, Marc;
    • Herdener, Marcus;
    • Torrens, Marta;
    • Gálvez, Bartolomé P.;
    • Gual, Antoni;
    • Corral, Ricardo M.;
    • Kuper, Enrique I.;
    • Mosca, Daniel L.;
    • Dumitras, Swati;
    • Pezous, Nicole;
    • Berkheimer, Maria;
    • Walker, Ela;
    • Gasparini, Fabrizio;
    • Cha, Jang-Ho;
    • Dolmetsch, Ricardo
    Publication type:
    Article
    15

    Development of and its potential for the treatment of fragile X syndrome.

    Published in:
    Expert Opinion on Investigational Drugs, 2014, v. 23, n. 1, p. 125, doi. 10.1517/13543784.2014.857400
    By:
    • Gomez-Mancilla, Baltazar;
    • Berry-Kravis, Elizabeth;
    • Hagerman, Randi;
    • von Raison, Florian;
    • Apostol, George;
    • Ufer, Mike;
    • Gasparini, Fabrizio;
    • Jacquemont, Sébastien
    Publication type:
    Article
    16

    Reciprocal changes in DNA methylation and hydroxymethylation and a broad repressive epigenetic switch characterize FMR1 transcriptional silencing in fragile X syndrome.

    Published in:
    Clinical Epigenetics, 2016, v. 8, p. 1, doi. 10.1186/s13148-016-0181-x
    By:
    • Brasa, Sarah;
    • Mueller, Arne;
    • Jacquemont, Sébastien;
    • Hahne, Florian;
    • Rozenberg, Izabela;
    • Peters, Thomas;
    • Yunsheng He;
    • McCormack, Christine;
    • Gasparini, Fabrizio;
    • Chibout, Salah-Dine;
    • Grenet, Olivier;
    • Moggs, Jonathan;
    • Gomez-Mancilla, Baltazar;
    • Terranova, Rémi
    Publication type:
    Article
    17
    18

    A Study of Novel Exploratory Tools, Digital Technologies, and Central Nervous System Biomarkers to Characterize Unipolar Depression.

    Published in:
    Frontiers in Psychiatry, 2021, v. 12, p. N.PAG, doi. 10.3389/fpsyt.2021.640741
    By:
    • Sverdlov, Oleksandr;
    • Curcic, Jelena;
    • Hannesdottir, Kristin;
    • Gou, Liangke;
    • De Luca, Valeria;
    • Ambrosetti, Francesco;
    • Zhang, Bingsong;
    • Praestgaard, Jens;
    • Vallejo, Vanessa;
    • Dolman, Andrew;
    • Gomez-Mancilla, Baltazar;
    • Biliouris, Konstantinos;
    • Deurinck, Mark;
    • Cormack, Francesca;
    • Anderson, John J.;
    • Bott, Nicholas T.;
    • Peremen, Ziv;
    • Issachar, Gil;
    • Laufer, Offir;
    • Joachim, Dale
    Publication type:
    Article
    19
    20

    The challenges of clinical trials in fragile X syndrome.

    Published in:
    Psychopharmacology, 2014, v. 231, n. 6, p. 1237, doi. 10.1007/s00213-013-3289-0
    By:
    • Jacquemont, Sébastien;
    • Berry-Kravis, Elizabeth;
    • Hagerman, Randi;
    • Raison, Florian;
    • Gasparini, Fabrizio;
    • Apostol, George;
    • Ufer, Mike;
    • Portes, Vincent;
    • Gomez-Mancilla, Baltazar
    Publication type:
    Article
    21
    22
    23
    24
    25
    26

    CSF-Tau and CSF-Aβ<sub>1–42</sub> in Posterior Cortical Atrophy.

    Published in:
    Dementia & Geriatric Cognitive Disorders, 2010, v. 29, n. 6, p. 530, doi. 10.1159/000314679
    By:
    • Baumann, Thomas P.;
    • Duyar, Hüseyin;
    • Sollberger, Marc;
    • Kuhle, Jens;
    • Regeniter, Axel;
    • Gomez-Mancilla, Baltazar;
    • Schmidtke, Klaus;
    • Monsch, Andreas U.
    Publication type:
    Article
    27
    28
    29
    30

    MIJ821 (onfasprodil) in healthy volunteers: First‐in‐human, randomized, placebo‐controlled study (single ascending dose and repeated intravenous dose).

    Published in:
    CTS: Clinical & Translational Science, 2023, v. 16, n. 11, p. 2236, doi. 10.1111/cts.13623
    By:
    • Gomez‐Mancilla, Baltazar;
    • Levy, Jeffrey A.;
    • Ganesan, Subramanian;
    • Faller, Thomas;
    • Issachar, Gil;
    • Peremen, Ziv;
    • Laufer, Offir;
    • Shani‐Hershkovich, Revital;
    • Biliouris, Kostas;
    • Walker, Ela;
    • Healy, Mark P.;
    • Sverdlov, Oleksandr;
    • Desai, Sachin;
    • Ghaemi, S. Nassir;
    • Cha, Jang‐Ho;
    • Shanker, Y. Gopi
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38

    Pharmacogenetics and Pharmacogenomics in Drug Development and Regulatory Decision Making: Report of the First FDA-PWG-PhRMA-DruSafe Workshop.

    Published in:
    Journal of Clinical Pharmacology, 2003, v. 43, n. 4, p. 342
    By:
    • Lawrence J. Lesko;
    • Ronald A. Salerno;
    • Brian B. Spear;
    • Donald C. Anderson;
    • Timothy Anderson;
    • Celia Brazell;
    • Jerry Collins;
    • Andrew Dorner;
    • David Essayan;
    • Baltazar Gomez-Mancilla;
    • Joseph Hackett;
    • Shiew-Mei Huang;
    • Susan Ide;
    • Joanne Killinger;
    • John Leighton;
    • Elizabeth Mansfield;
    • Robert Meyer;
    • Stephen G. Ryan;
    • Virginia Schmith;
    • Peter Shaw
    Publication type:
    Article
    39
    40
    41
    42
    43

    Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks.

    Published in:
    Cephalalgia, 2014, v. 34, n. 2, p. 103, doi. 10.1177/0333102413499648
    By:
    • Gomez-Mancilla, Baltazar;
    • Brand, Ronald;
    • Jürgens, Tim P;
    • Göbel, Harmut;
    • Sommer, Claudia;
    • Straube, Andreas;
    • Evers, Stefan;
    • Sommer, Martin;
    • Campos, Victor;
    • Kalkman, Hans O;
    • Hariry, Sam;
    • Pezous, Nicole;
    • Johns, Donald;
    • Diener, Hans-Christoph
    Publication type:
    Article
    44

    Protein synthesis levels are increased in a subset of individuals with fragile X syndrome.

    Published in:
    Human Molecular Genetics, 2018, v. 27, n. 12, p. 2039, doi. 10.1093/hmg/ddy099
    By:
    • Jacquemont, Sébastien;
    • Pacini, Laura;
    • Jønch, Aia E.;
    • Cencelli, Giulia;
    • Rozenberg, Izabela;
    • Yunsheng He;
    • D'Andrea, Laura;
    • Pedini, Giorgia;
    • Eldeeb, Marwa;
    • Willemsen, Rob;
    • Gasparini, Fabrizio;
    • Tassone, Flora;
    • Hagerman, Randi;
    • Gomez-Mancilla, Baltazar;
    • Bagni, Claudia
    Publication type:
    Article
    45